2020 NIH Research Festival Exhibit
September 17-18, 2020
A Celebration of Intramural Science
The 2020 NIH Research Festival is your most direct link to the NIH community. The Technical Sales Association (TSA), a nationwide, member-led organization based in greater Metropolitan Washington, D.C. invites you to exhibit at its foremost event of the year hosted at the Bethesda campus of NIH, a long-time hub of activity for TSA members. This 31st annual event has emerged as the region’s largest onsite exhibit in the biomedical research community – and your most valuable marketing link to NIH decision-makers. The 2020 exhibit will again be held on Lot 10H. This location affords superb visibility, easy access and a strategic location in relation to the rest of the campus. The 2019 exhibit featured more than 275 exhibit booths showcasing the latest product developments of more than 250 national and regional vendors – the single largest representation of TSA member suppliers. Likewise, a record number attendance of well more than 2,500 research professionals from the NIH community and neighboring facilities is expected at this annual event. The FY 2020 budget requests $41.6 billion for the National Institutes of Health which represents a 7% increase over 2019. The 2020 exhibit is your best opportunity to gain a share of this highly valuable market. Exhibitors will again have the opportunity to select a desired booth location and apply for more than one booth.
NATIONAL INSTITUTES OF HEALTH
Begun as a one-room laboratory of hygiene in 1887, the National Institutes of Health today is one of the world’s foremost biomedical research centers, and the Federal focal point for biomedical research in the United States.
The NIH mission is to expand fundamental knowledge about the nature and behavior of living systems and to improve and develop new strategies for the diagnosis, treatment, and prevention of disease and communicate the results of research with the goal of improving health. NIH works toward that mission by conducting research in its own laboratories; supporting the research of non-federal scientists in universities, medical schools, hospitals and research institutions throughout the country and abroad; helping in the training of research investigators; and fostering communication of biomedical information.
The NIH is one of eight health agencies of the Public Health Service which, in turn, is part of the U.S. Department of Health and Human Services. Comprised of 28 separate Institutes and Centers, NIH has 85 buildings on more than 300 acres in Bethesda, Maryland. From a total of about $300 in 1887, the NIH budget has grown to exceed $34 billion in 2019.
Simply described, the goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose and treat disease and disability, from the rarest genetic disorder to the common cold. Scientific progress depends mainly on the scientist. About 50,000 principal investigators – working in every state and in several foreign countries, from every specialty in medicine, every biomedical discipline and at every major university and medical school – receive NIH extramural funding to explore unknown areas of biomedical science.
The National Institutes of Health serves the American public through the support and conduct of research. We have reached the dawn of a new century in which the average life expectancy in the United States has increased by nearly 30 years – an accomplishment realized in part, by research-based improvements in health. Continued improvements in the practice of medicine and health are possible if we are prepared to take advantage of the achievements in fundamental science and informatics, including advanced computing imaging.
The FY 2020 program level for the NIH is $41.6 billion. As a result of this continued high-level funding of its budget, the Institutes and Centers (ICs) at the NIH have many new research initiatives underway, all of which will be continued in FY 2020 and beyond. This continued support of medical research will pay real dividends in the years to come – dividends in the form of new scientific knowledge, new treatments, new diagnostic tools, new cures, and new ways to prevent disease before it strikes.